(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(2.18%) $83.12
(1.92%) $1.751
(1.74%) $2 251.30
(1.39%) $25.10
(1.44%) $922.80
(0.39%) $0.927
(0.89%) $10.86
(0.11%) $0.792
(0.15%) $92.58
Live Chart Being Loaded With Signals
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel...
Stats | |
---|---|
Today's Volume | 13 212.00 |
Average Volume | 205 444 |
Market Cap | 7.71M |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.670 |
ATR14 | $0 (0.00%) |
Hera Med Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Hera Med Ltd Financials
Annual | 2023 |
Revenue: | $606 986 |
Gross Profit: | $-300 006 (-49.43 %) |
EPS: | $-0.0251 |
Q4 | 2023 |
Revenue: | $308 878 |
Gross Profit: | $-232 170 (-75.17 %) |
EPS: | $-0.0120 |
Q2 | 2023 |
Revenue: | $298 071 |
Gross Profit: | $-70 535.00 (-23.66 %) |
EPS: | $-0.0131 |
Q4 | 2022 |
Revenue: | $117 824 |
Gross Profit: | $-205 746 (-174.62 %) |
EPS: | $-0.0104 |
Financial Reports:
No articles found.
Hera Med Ltd
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators